Abstract 3932: Multi-omics characterization of molecular features and global-local genomic ancestry analysis of colorectal cancer in Hispanic-Latinos
Enrique I. Velazquez Villarreal(Keck Hospital of USC), John D. Carpten(City of Hope), Mackenzie Postel(University of Southern California), Donna Loza(University of Southern California), Seeta Rajpara(University of Southern California), David W. Craig(City of Hope), Flemming Wu(Keck Hospital of USC), Brigette Waldrup(Keck Hospital of USC), Heinz‐Josef Lenz(USC Norris Comprehensive Cancer Center), Yuxin Jin(Chongqing University)
Cited by 0
Related Papers
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
|The Lancet Oncology|2017|2.8k
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer
|Journal of Clinical Oncology|2018|2.1k
Prognostic and Predictive Relevance of Primary Tumor Location in Patients With <i>RAS </i>Wild-Type Metastatic Colorectal Cancer
|JAMA Oncology|2016|722
The secreted glycoprotein lubricin protects cartilage surfaces and inhibits synovial cell overgrowth
|Journal of Clinical Investigation|2005|524